Back
Janux Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
32
JANX
Janux Therapeutics
Last Price:
$25.39
Seasonality Move:
-3.13%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing slight buying pressure.
Janux Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.71 | Sell |
20-day SMA: | 28.32 | Sell |
50-day SMA: | 28.73 | Sell |
200-day SMA: | 42.26 | Sell |
8-day EMA: | 24.94 | Sell |
20-day EMA: | 26.86 | Sell |
50-day EMA: | 29.74 | Sell |
200-day EMA: | 37.39 | Sell |
Janux Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.68 | Sell |
Relative Strength Index (14 RSI): | 37.86 | Sell |
Chaikin Money Flow: | 160605 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.23 - 31.73) | Sell |
Bollinger Bands (100): | (26.52 - 45.28) | Sell |
Janux Therapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Janux Therapeutics Stock
Is Janux Therapeutics Stock a Buy?
-
Janux Therapeutics share price is 24.17 while JANX 8-day simple moving average is 24.71, which is a Sell signal.
-
The stock price of JANX is 24.17 while Janux Therapeutics 20-day SMA is 28.32, which makes it a Sell.
-
Janux Therapeutics 50-day simple moving average is 28.73 while JANX share price is 24.17, making it a Sell technically.
-
JANX stock price is 24.17 and Janux Therapeutics 200-day simple moving average is 42.26, creating a Sell signal.
JANX Technical Analysis vs Fundamental Analysis
Sell
32
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy or a Sell?
-
Janux Therapeutics stock is rated a SellThe current Janux Therapeutics [JANX] share price is $24.17. The Score for JANX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Janux Therapeutics Stock Info
Market Cap:
1.4B
Price in USD:
24.17
Share Volume:
886K
Janux Therapeutics 52-Week Range
52-Week High:
71.71
52-Week Low:
22.48
Sell
32
Janux Therapeutics (JANX)
is a Sell
Janux Therapeutics Share Price Forecast
-
What is the Janux Therapeutics stock price today?The Janux Therapeutics stock price is 24.17 USD today.
-
Will JANX stock go up or go down?Janux Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Janux Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Janux Therapeutics is overvalued.
Is Janux Therapeutics Stock a Buy?
-
Janux Therapeutics share price is 24.17 while JANX 8-day exponential moving average is 24.94, which is a Sell signal.
-
The stock price of JANX is 24.17 while Janux Therapeutics 20-day EMA is 26.86, which makes it a Sell.
-
Janux Therapeutics 50-day exponential moving average is 29.74 while JANX share price is 24.17, making it a Sell technically.
-
JANX stock price is 24.17 and Janux Therapeutics 200-day simple moving average is 37.39, creating a Sell signal.
Fundamental Analysis of Janux Therapeutics
Is Janux Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.30 per share, a decrease this year of $0.81 per share, and a decrease next year of $0.71 per share.
Technical Analysis of Janux Therapeutics
Should I short Janux Therapeutics stock?
-
JANX Moving Average Covergence Divergence (MACD) indicator is -1.68, suggesting Janux Therapeutics is a Sell
-
Janux Therapeutics Relative Strength Index (RSI) is 37.86, which suggest Janux Therapeutics is oversold
-
The Bollinger Bands (25) for Janux Therapeutics is (25.23 - 31.73), which suggest Janux Therapeutics is a Sell
-
The Bollinger Bands (100) for Janux Therapeutics is (26.52 - 45.28), which suggest Janux Therapeutics is a Sell
* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.